Next Investors logo grey
  1. Home
  2. Vaccine

Vaccine

Vaccine rollout could give AstraZeneca shares a shot in the arm … and 2 Oz small caps to watch

Finfeed Archived Feb 12, 2021

As Australia prepares to roll out its first COVID-19 vaccine, (and the citizens of Melbourne enter lockdown 4.0) it’s worth looking at the impact the roll-out will have on its maker – AstraZeneca.

Achiko emerges as strong Covid-19 beneficiary

Finfeed Archived Dec 17, 2020

Achiko (SWX: ACHI), listed on the Switzerland Stock Exchange during the year, is transforming into a health technology company with the rapid development of Teman Sehat, an open source software product that provides an alternative way to manage Covid-19 testing, and ‘Gumnuts’, a potential rapid and low-cost virus detection technology.

The biggest deal of 2020?

Finfeed Archived Dec 01, 2020

The WSJ, financial information firm S&P Global is in advanced talks to buy fellow data giant IHS Markit for $44BN. If that price stands, the deal would be the largest in the US this year.

COVID vaccine sees global markets soar

Finfeed Archived Nov 10, 2020

The announcement that Pfizer and BioNTech’s COVID-19 vaccine was 90% effective in tests saw global markets soar overnight.

Could PAA’s lead cancer drug treatment treat COVID-19?

Finfeed Archived Apr 17, 2020

PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.

Join Our
Mailing List